EMIS Acquires Majority Stake in Pharmacy Software Company Rx Systems Limited

EMIS Group plcEMIS Group plc (AIM: EMIS), the UK's leading supplier of healthcare software to GPs, today announces that it has acquired 78.9% of the issued share capital of Rx Systems Limited ("RX"), a pharmacy software and services company, for a total consideration of up to £9.95 million.

Rx Systems has a 20.5% share of the community pharmacy market; EMIS believes that further growth in the market share can be achieved post-acquisition.

The acquisition is an important element of EMIS' continuing drive to provide 'joined-up' healthcare for NHS patients. It is anticipated that future integration of EMIS and Rx Systems technologies will enable further streamlining of electronic prescription services, benefiting patients, GPs and the 2,500 community pharmacies using Rx Systems' ProScript dispensary management system.

Future developments will see pharmacists benefit from the link with GP practices using EMIS Access, the award winning secure online patient portal. This already allows patients to request repeat medication via internet, mobile phone or digital TV, saving time and streamlining the prescription process considerably.

There will be further advantages from interoperability between EMIS Web, EMIS' next generation system, and ProScript. EMIS Web is currently being tested for EPS2 paired with ProScript.

Sean Riddell, EMIS CEO, said: "Rx Systems software has a strong reputation and a loyal community pharmacy customer base. Joining forces enables both EMIS and Rx Systems to identify the best way to provide GPs and pharmacists with appropriate levels of interoperability to further improve patient care and efficiencies in the prescribing environment. This means real benefits for patients, GPs and pharmacists alike."

For further information, please visit:
http://www.emis-online.com

Related news articles:

EPS2 (Release 2 of Connecting for Health's Electronic Prescription System) will provide increased functionality for pharmacists, GPs and patients including nomination of pharmacies, electronic prescription signing and electronic repeat dispensing.

About EMIS Group plc
EMIS was established in March 1987 by two GPs who identified an opportunity to develop and supply practice management software and computerise patients’ electronic health records, then kept on paper at GPs' surgeries.

The Group has since become the UK's leading supplier of software and related services to GP surgeries and now leads the market, with around 39 million patient records held on its platform.

The Group's latest product, EMIS Web, electronically connects GPs with other NHS professionals by enabling secure, shared, centrally hosted access to patients' cradle-to-grave electronic health records held at the Group’s data centres. The transformational system has the capability to interconnect with other NHS patient data systems to:

  • save time and money by eliminating paperwork and the re-inputting of data;
  • significantly reduce patient waiting times; and
  • reduce the risk of prescribing and treatment errors.

EMIS is headquartered in Leeds.

About Rx Systems
Rx Systems has grown rapidly since it began trading in 2004. Based in Hertfordshire and operating throughout the UK, Rx Systems has developed a range of integrated pharmacy and retail systems and services for the community pharmacy, including its core product, ProScript, a windows based dispensary management system. www.rxsystems.co.uk.

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...